Macclesfield, United Kingdom

Paul Richard Gellert

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Cheshire, GB (2007)
  • Macclesfield, GB (2023)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Paul Richard Gellert: Innovator in Pharmaceutical Compositions

Introduction

Paul Richard Gellert is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work focuses on innovative compositions that have the potential to improve medical treatments.

Latest Patents

Gellert's latest patents include a pharmaceutical composition that concerns a hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide. This invention also covers solvates, crystalline forms, and amorphous forms of the compound, emphasizing its use as a medicament and detailing processes for the preparation of these compositions.

Career Highlights

Throughout his career, Gellert has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Array Biopharma. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation.

Collaborations

Gellert has collaborated with several professionals in his field, including Kathryn Jane Hill and Nicola Frances Bateman. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Paul Richard Gellert is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact medical science significantly. His innovative contributions and collaborations highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…